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Aggressive pharmacologic strategies dramatically lower
incidence of MI and CVA. Yet, when examined at the arte-
rial lumen, only nominal changes are seen. CMR, able to
detect by 2D (single slice) underlying plaque characteris-
tics, currently has not identified such features by 3D. A 3D
volumetric approach may better define plaque 'vulnera-
bility' while disentangling this conundrum.
Hypothesis
We hypothesize that in statin-naive pts with high grade
carotid artery disease, 3D CMR integrates plaque compo-
nents with lipid fractions superior to 2D while solving the
'disassociation' between outcome and % stenosis.
Methods
Via CMR (1.5 T GE, WI), 860-two mm contiguous in vivo
slices of advanced carotid disease (>50%; mean 63 ± 22)
representing 38 complete bilateral human plaques (age
65 ± 13 yrs) were analyzed for 2D and 3D extent of vascu-
lar wall: lipid pool, fibrous cap, matrix and minima/
maxima of each. All were related to fasting lipids relative
to %stenosis via QPlaque (Medis, The Netherlands).
Plaque morphology was determined by T1 and T2/PD.
Results
35/38 in vivo plaques were successfully imaged. Mean res-
olution: 1 × 1 × 2 mm. The mg/dL range of LDL was 63-
186, HDL: 25-70 and TG: 81-213. Lipid pool represented
19 ± 8% and fibrous plaque 9 ± 24% of total vessel wall.
LDL, not total cholesterol (CholT), was related to mean
fibrous cap (mm) (r = 0.6 p = < 0.05) while triglycerides
were related to max fibrous cap but inversely to the lipid
pool (r = 0.6, -0.5, p < 0.05 for both). The LDL:HDL and
CholT:HDL ratios were related to fibrous cap (r = 0.6, p <
0.05 for both). The CholT: LDL was related to min fibrous
cap (mm) (r = 0.7 p < 0.05). Via 3D volumetrics only HDL
was related to lipid volume while CholT, LDL, LDL: HDL
and CholT:HDL ratios were all related to fibrous cap vol-
ume (r > 0.5-0.7, p < 0.005 for all). Importantly, relating
% stenosis to any vessel wall component or its ratio
revealed no relationship.
Conclusion
CMR can depict plaque composition demonstrating
important relationships with common lipid fractions and
even stronger relations via 3D volumetrics not visible by
2D approaches. Critically, in statin-naive pts, 3D CMR
defined plaque morphology is highly related to 'clinical
risk' not % luminal stenosis, potentially serving as an eas-
ily identifiable marker and thus solving the quandary.
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